Sign in
CERO Stock Price, Chart, Stats & News
CERo Therapeutics Holdings, Inc.
Save
CERo Therapeutics Holdings, Inc. (CERO) does not currently pay a dividend.
496,236
Market cap
–
Current P/E
–
Forward P/E
CERO chart
About
Health care
Sector
Biotechnology
Industry
CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers. Their leading therapeutic candidate, CER-1236, is an autologous T-cell therapy currently in development, aimed at addressing both blood cancers (hematologic malignancies) and solid tumors. This company was founded in 2021 and is headquartered in South San Francisco, California.
Similar securities
Based on sector and market capitalization
Report issue